Logo

Divi's Laboratories Ltd. Share Price

Pharmaceuticals & Drugs

Divi's Laboratories Ltd. (INR)6012.5-203   (-3.3%)

Exchange ScripsBSE532488NSEDIVISLABISININE361B01024

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Divi's Laboratories Ltd. Performance

Market performance

Open price6240
High6285
Volumes964571
Prev Close6012.5
Low5964.5
Closing date2025-04-25

Historical performance

1 Year High6308.50
3 Year High6308.50
5 Year High6308.50
1 Year Low3724.00
3 Year Low2730.00
5 Year Low2090.05

Divi's Laboratories Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
165241
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
99.58
Dividend Yield
Dividend Yield
0.25 %

Divi's Laboratories Ltd. Investment Returns

1 Year
56.4%
3 Years
36.3%
5 Years
147.9%
10 Years
577%

Divi's Laboratories Ltd. Technicals

IndicatorsValueSignal
5-DMA5991.1Bullish
10-DMA5805.95Bullish
20-DMA5724.76Bullish
50-DMA5743.32Bullish
100-DMA5826.71Bullish
200-DMA5576.09Bullish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors267749280595278893298304347623
Government3321---

Divi's Laboratories Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income339034501159627
Operating Profit25450271403997029237
Interest40202021
Depreciation3780343031152556
Profit Before Tax21630236903683526660
Consolidated Net Profit16000182402960419843
Adjusted EPS606911275

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital530530531531
Total Reserves13518012714011675192415
Minority Interest------------
Total Non-Current Liabilities6110557043653639
Total Liabilities159370148630146191113869
Capital Work in Progress7780212046997106
Total Assets159370148630146191113869

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities12610245901911819469
Cash Flow from Investing Activities-2690-27070-21949751
Cash Flow from Financing Activitie-7990-7970-5324-349
Net Cash Inflow / Outflow1930-10450-815619872
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 99.58.
  • 3Y Stock Price CAGR of the stock is 10.0.
  • The stock has a beta of 0.7.
  • In the last financial year, the company had an EBITDA of ₹25450 Million.
  • The company generated revenue of ₹78450 Million in the previous financial year.

Divi's Laboratories Ltd.

6012.5-203   (-3.3%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1497006
No. of Shares: 249.0
Performance:49.7%
P/L: ₹497006

Top Gainers

SymbolChange%
LFIC203.61(20%)
CARRARO386.55(17%)
MANAKSTEEL73.32(15%)
BUTTERFLY700.45(15%)
COUNCODOS10.84(10%)

Top Losers

SymbolChange%
BHANDARI4.85(-11%)
SRM321.35(-11%)
MINDTECK208.55(-10%)
OSWALAGRO87.03(-9%)
PVP25.67(-9%)
AMDIND46.95(-9%)
MAGNUM27.9(-9%)
VSTIND302.75(-8%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

52.3

55.87

March 25 - April 25

Hester Biosciences Ltd.

40.9

1940.5

March 25 - April 25

SMS Lifesciences India Ltd.

33.7

1448.9

March 25 - April 25

Sakar Healthcare Ltd.

27.8

291.03

March 25 - April 25

Natural Capsules Ltd.

27.1

216.37

March 25 - April 25

Brooks Laboratories Ltd.

25.1

139.83

March 25 - April 25

Valiant Laboratories Ltd.

21.6

99.25

March 25 - April 25

Panacea Biotec Ltd.

20.7

520.8

March 25 - April 25

Announcing Stock of the Month!

Stock of the Month
Stock of the Month